The constitutive expression of CTLA-4 in pituitary endocrine cells explains the occurrence of hypophysitis in patients receiving anti-CTLA-4 [50] and highlights the importance of this potential mechanism due to constitutive expression of checkpoints in normal tissues. Here, CTLA4 is linked to hypophysitis.